Literature DB >> 29258818

Remodeling of HIV-1 Nef Structure by Src-Family Kinase Binding.

Jamie A Moroco1, John Jeff Alvarado2, Ryan P Staudt2, Haibin Shi3, Thomas E Wales4, Thomas E Smithgall5, John R Engen6.   

Abstract

The HIV-1 accessory protein Nef controls multiple aspects of the viral life cycle and host immune response, making it an attractive therapeutic target. Previous X-ray crystal structures of Nef in complex with key host cell binding partners have shed light on protein-protein interactions critical to Nef function. Crystal structures of Nef in complex with either the SH3 or tandem SH3-SH2 domains of Src-family kinases reveal distinct dimer conformations of Nef. However, the existence of these Nef dimer complexes in solution has not been established. Here we used hydrogen exchange mass spectrometry (HX MS) to compare the solution conformation of Nef alone and in complexes with the SH3 or the SH3-SH2 domains of the Src-family kinase Hck. HX MS revealed that interaction with the Hck SH3 or tandem SH3-SH2 domains induces protection of the Nef αB-helix from deuterium uptake, consistent with a role for αB in dimer formation. HX MS analysis of a Nef mutant (position Asp123, a site buried in the Nef:SH3 dimer but surface exposed in the Nef:SH3-SH2 complex), showed a Hck-induced conformational change in Nef relative to wild-type Nef. These results support a model in which Src-family kinase binding induces conformational changes in Nef to expose residues critical for interaction with the μ1 subunit of adaptor protein 1 and the major histocompatibility complex-1 tail, and subsequent major histocompatibility complex-1 downregulation and immune escape of HIV-infected cells required for functional interactions with downstream binding partners.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HIV-1 accessory factors; Src-homology domains; conformational change; host–pathogen interactions; hydrogen exchange mass spectrometry

Mesh:

Substances:

Year:  2017        PMID: 29258818      PMCID: PMC5801098          DOI: 10.1016/j.jmb.2017.12.008

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  45 in total

1.  Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef.

Authors:  M Geyer; B M Peterlin
Journal:  FEBS Lett       Date:  2001-05-11       Impact factor: 4.124

2.  Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor.

Authors:  R Salvi; A R Garbuglia; A Di Caro; S Pulciani; F Montella; A Benedetto
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Conformational features of the full-length HIV and SIV Nef proteins determined by mass spectrometry.

Authors:  James M Hochrein; Thomas E Wales; Edwina C Lerner; Anthony P Schiavone; Thomas E Smithgall; John R Engen
Journal:  Biochemistry       Date:  2006-06-27       Impact factor: 3.162

4.  Membrane-Associated Conformation of HIV-1 Nef Investigated with Hydrogen Exchange Mass Spectrometry at a Langmuir Monolayer.

Authors:  Gregory F Pirrone; Lori A Emert-Sedlak; Thomas E Wales; Thomas E Smithgall; Michael S Kent; John R Engen
Journal:  Anal Chem       Date:  2015-07-02       Impact factor: 6.986

5.  Cell-based Fluorescence Complementation Reveals a Role for HIV-1 Nef Protein Dimerization in AP-2 Adaptor Recruitment and CD4 Co-receptor Down-regulation.

Authors:  Sherry T Shu; Lori A Emert-Sedlak; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

6.  Identification of attenuated variants of HIV-1 circulating recombinant form 01_AE that are associated with slow disease progression due to gross genetic alterations in the nef/long terminal repeat sequences.

Authors:  Makiko Kondo; Takako Shima; Masako Nishizawa; Koji Sudo; Shinya Iwamuro; Takeshi Okabe; Yutaka Takebe; Mitsunobu Imai
Journal:  J Infect Dis       Date:  2005-05-25       Impact factor: 5.226

7.  Effector kinase coupling enables high-throughput screens for direct HIV-1 Nef antagonists with antiretroviral activity.

Authors:  Lori A Emert-Sedlak; Purushottam Narute; Sherry T Shu; Jerrod A Poe; Haibin Shi; Naveena Yanamala; John Jeff Alvarado; John S Lazo; Joanne I Yeh; Paul A Johnston; Thomas E Smithgall
Journal:  Chem Biol       Date:  2013-01-24

8.  The accessory factor Nef links HIV-1 to Tec/Btk kinases in an Src homology 3 domain-dependent manner.

Authors:  Sreya Tarafdar; Jerrod A Poe; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2014-04-10       Impact factor: 5.157

9.  Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Authors:  N J Deacon; A Tsykin; A Solomon; K Smith; M Ludford-Menting; D J Hooker; D A McPhee; A L Greenway; A Ellett; C Chatfield; V A Lawson; S Crowe; A Maerz; S Sonza; J Learmont; J S Sullivan; A Cunningham; D Dwyer; D Dowton; J Mills
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

10.  Discovery of a diaminoquinoxaline benzenesulfonamide antagonist of HIV-1 Nef function using a yeast-based phenotypic screen.

Authors:  Ronald P Trible; Purushottam Narute; Lori A Emert-Sedlak; John Jeff Alvarado; Katelyn Atkins; Laurel Thomas; Toshiaki Kodama; Naveena Yanamala; Vasiliy Korotchenko; Billy W Day; Gary Thomas; Thomas E Smithgall
Journal:  Retrovirology       Date:  2013-11-14       Impact factor: 4.602

View more
  9 in total

1.  Tight-Binding Hydroxypyrazole HIV-1 Nef Inhibitors Suppress Viral Replication in Donor Mononuclear Cells and Reverse Nef-Mediated MHC-I Downregulation.

Authors:  Haibin Shi; Colin M Tice; Lori Emert-Sedlak; Li Chen; Wing Fai Li; Marianne Carlsen; Jay E Wrobel; Allen B Reitz; Thomas E Smithgall
Journal:  ACS Infect Dis       Date:  2019-12-16       Impact factor: 5.084

Review 2.  Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes.

Authors:  Ryan P Staudt; John J Alvarado; Lori A Emert-Sedlak; Haibin Shi; Sherry T Shu; Thomas E Wales; John R Engen; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2020-08-29       Impact factor: 5.157

3.  HIV-1 Nef dimers short-circuit immune receptor signaling by activating Tec-family kinases at the host cell membrane.

Authors:  Wing Fai Li; Manish Aryal; Sherry T Shu; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2020-03-06       Impact factor: 5.157

Review 4.  Mass Spectrometry-Based Structural Virology.

Authors:  Tobias P Wörner; Tatiana M Shamorkina; Joost Snijder; Albert J R Heck
Journal:  Anal Chem       Date:  2020-12-04       Impact factor: 6.986

5.  Ubiquitin E3 Ligase c-Cbl Is a Host Negative Regulator of Nef Protein of HIV-1.

Authors:  Hong-Guang Zhang; Jing Guo; Yukang Yuan; Yibo Zuo; Jin Liu; Li Zhu; Ying Miao; Xiangjie Chen; Lincong Jin; Fan Huang; Tengfei Ren; Jiuyi He; Weifeng Shi; Zhenke Wen; Chuanwu Zhu; Hui Zheng; Chunsheng Dong; Feng Qian
Journal:  Front Microbiol       Date:  2020-11-19       Impact factor: 5.640

Review 6.  Antiretroviral Drug Discovery Targeting the HIV-1 Nef Virulence Factor.

Authors:  Lori A Emert-Sedlak; Haibin Shi; Colin M Tice; Li Chen; John J Alvarado; Sherry T Shu; Shoucheng Du; Catherine E Thomas; Jay E Wrobel; Allen B Reitz; Thomas E Smithgall
Journal:  Viruses       Date:  2022-09-13       Impact factor: 5.818

7.  A single β-octyl glucoside molecule induces HIV-1 Nef dimer formation in the absence of partner protein binding.

Authors:  Mousheng Wu; John J Alvarado; Corinne E Augelli-Szafran; Roger G Ptak; Thomas E Smithgall
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

8.  Mitochondrial ClpX activates an essential biosynthetic enzyme through partial unfolding.

Authors:  Julia R Kardon; Jamie A Moroco; John R Engen; Tania A Baker
Journal:  Elife       Date:  2020-02-24       Impact factor: 8.140

9.  Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals.

Authors:  Mako Toyoda; Doreen Kamori; Toong Seng Tan; Kageaki Goebuchi; Jun Ohashi; Jonathan Carlson; Ai Kawana-Tachikawa; Hiroyuki Gatanaga; Shinichi Oka; Massimo Pizzato; Takamasa Ueno
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.